Walkner Condon Financial Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,217
Closed -$1.03M 329
2025
Q4
$1.03M Buy
11,217
+1,588
+16% +$128K 0.14% 111
2025
Q3
$500K Buy
9,629
+57
+0.6% +$2.85K 0.08% 170
2025
Q2
$487K Buy
9,572
+142
+2% +$7.21K 0.09% 163
2025
Q1
$418K Buy
9,430
+913
+11% +$46.2K 0.08% 175
2024
Q4
$447K Buy
8,517
+534
+7% +$33.2K 0.09% 174
2024
Q3
$467K Sell
7,983
-458
-5% -$25.8K 0.1% 164
2024
Q2
$357K Sell
8,441
-3,840
-31% -$211K 0.08% 178
2024
Q1
$848K Buy
12,281
+1,386
+13% +$87.7K 0.18% 107
2023
Q4
$806K Sell
10,895
-526
-5% -$34.5K 0.18% 109
2023
Q3
$779K Sell
11,421
-901
-7% -$76.4K 0.21% 101
2023
Q2
$1.16M Sell
12,322
-1,530
-11% -$119K 0.31% 72
2023
Q1
$939K Buy
13,852
+865
+7% +$55.6K 0.26% 85
2022
Q4
$643K Buy
12,987
+367
+3% +$15K 0.19% 101
2022
Q3
$410K Buy
12,620
+169
+1% +$6.97K 0.13% 136
2022
Q2
$490K Sell
12,451
-52
-0.4% -$2.78K 0.15% 119
2022
Q1
$874K Buy
+12,503
New +$914K 0.25% 83
2021
Q4
Sell
-2,679
Closed -$257K 132
2021
Q3
$257K Buy
2,679
+485
+22% +$51.2K 0.13% 122
2021
Q2
$273K Buy
2,194
+170
+8% +$20.3K 0.1% 140
2021
Q1
$267K Buy
2,024
+485
+32% +$66.4K 0.1% 143
2020
Q4
$204K Buy
+1,539
New +$186K 0.09% 134

Other funds holding EXAS

Walkner Condon Financial Advisors's EXAS Position: Q1 2026 in Review

Walkner Condon Financial Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 11,217 shares — an estimated $1.03M sold.

Walkner Condon Financial Advisors first reported a position in EXAS in Q4 2020 and held it in 20 quarters. The position peaked at $1.16M in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Walkner Condon Financial Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Walkner Condon Financial Advisors sold 11,217 Exact Sciences shares in Q1 2026, an estimated $1.03M.
  • Walkner Condon Financial Advisors first reported a position in Exact Sciences in Q4 2020 and held it in 20 quarters.
  • Walkner Condon Financial Advisors's Exact Sciences position peaked at $1.16M in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Walkner Condon Financial Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.